Table 3.
Correlations supine healthy controls versus ME/CFS patients |
Slope difference | |||
---|---|---|---|---|
Healthy Controls | ME/CFS patients | p-value | ||
Correlation supine | R and p-value | Correlation supine | R and p-value | |
Y = −0,9769 *X + 99,18 | 0.52; < 0.0001 | Y = −0,7510 *X + 97,86 | 0.42; < 0.0001 | 0.39 |
Correlations end-tilt healthy controls versus ME/CFS patients | ||||
Correlation end-tilt | R and p-value | Correlation end-tilt | R and p-value | |
Y = −1968 *X + 130,7 | 0.68; < 0.0001 | Y = −1066 *X + 108,4 | 0.39; < 0.0001 | 0.0063 |
Correlations healthy controls: supine versus end-tilt |
Slope difference | |||
---|---|---|---|---|
Supine | End-tilt | p-value | ||
Correlation | R and p-value | Correlation | R and p-value | |
Y = −0,9769 *X + 99,18 | 0.52; < 0.0001 | Y = −1968 *X + 130,7 | 0.68; < 0.0001 | 0.0095 |
Correlations ME/CFS patients: supine versus end-tilt | ||||
correlation | R and p-value | correlation | R and p-value | |
Y = −0,7510 *X + 97,86 | 0.42; < 0.0001 | Y = −1066 *X + 108,4 | 0.39; < 0.0001 | 0.045 |
ME/CFS: myalgic encephalomyelitis. X = stroke volume index, Y = heart rate; A p-value of < 0.01 is considered statistically significant.